The Optune Lua system

Optune Lua is a wearable and portable treatment for MPM1,2

  • Optune Lua allows patients to go about their daily routine while continuously receiving treatment for MPM

Loco-regional delivery of Tumor Treating Fields (TTFields) via transducer arrays provides antimitotic activity directly at the site of the malignancy1

  • TTFields are added to pemetrexed + cisplatin or carboplatin systemic therapies
  • The size and placement of transducer arrays are customized based on gender, body type, and tumor location Novocure® will provide a customized map for array placement based on patient-specific measurements and tumor location (determined via CT scans).
  • It is recommended that Optune Lua is turned on at least 75% of the time (18 hours per day)
    • Patients have the flexibility to decide which times of the day are best for them, including at night when sleeping
Loco-regional delivery of Tumor Treating Fields (TTFields) via transducer arrays

Transducer array placement video

See how transducer arrays are placed on your patient’s skin.

MPM, malignant pleural mesothelioma.

References: 1. Optune Lua. Instructions for Use for Unresectable Malignant Pleural Mesothelioma. Novocure; 2019. 2. Optune Lua. Patient Information and Operation Manual for Unresectable Malignant Pleural Mesothelioma. Novocure; 2019.

Next: MOA
Indications For Use
jump to isi

The Optune Lua System is indicated for the treatment of adult patients with unresect…

Leaving OptuneLua.com

Novocure® does not review the information contained on this website and/or database for content, accuracy, or completeness. Use of and access to this information is subject to the terms, limitations, and conditions set by the website and/or database producer.

Novocure makes no representation as to the accuracy or any other aspect of the information contained on such website and/or database, nor does Novocure necessarily endorse such website and/or database.